Back to Ovarian Cancer
NCT07143682
NCT07143682
Who may be able to join
Who might be able to join this trial:
- You are a woman with Polycystic Ovary Syndrome (PCOS) who has been having difficulty getting pregnant
- You have been chosen by your doctor to receive treatment to help trigger ovulation (the release of eggs)
Who may not be able to join:
- Your Body Mass Index (BMI) is either below 18 or 30 and above (a BMI calculator can help you check this)
- You have other known reasons for not getting pregnant, such as endometriosis, blocked or damaged fallopian tubes, or problems with the uterus (womb)
- The difficulty getting pregnant is related to your male partner's fertility (for example, problems with sperm)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Registry
clinicaltrials_gov
Start date
8 January 2023
Est. completion
24 May 2024
Where this trial is recruiting
Bangladesh
Primary endpoints
The number of participants having mature follicle (mean diameter ≥18mm); The number of participants having adequate endometrial thickness ( 7mm or more)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.